Dr Magdalena Harris

BA(hons) MA PhD

Associate Professor


15-17 Tavistock Place
United Kingdom


Dr Magdalena Harris is an Associate Professor in the Sociology of Health at LSHTM. Her expertise lies in qualitative methods and the social sciences of hepatitis C and harm reduction. She has been based at LSHTM since 2009, where she conducts a programme of research investigating the lived experience of hepatitis C, its treatment and prevention in the UK. Magdalena is a former recipient of an NIHR Post-Doctoral Fellowship (‘The Hepatitis C Treatment Journey’) and currently holds an NIHR Career Development Fellowship (‘Care and Prevent’). This mixed-method project extends beyond a focus on hepatitis C and qualitative methods. It is the first study in the UK to investigate the barriers and facilitators to skin and soft tissue infection (SSTI) care for people who inject drugs, and the first globally to explore the potential of urine screening in drug treatment settings for preventing SSTI-related kidney failure (AA amyloidosis).

Magdalena has an extensive track-record in academic-community partnership, peer research, and in disseminating research findings in close collaboration with community organisations. She is a trustee for the Hepatitis C Trust; associate editor for the International Journal of Drug Policy and Journal of Hepatology, Medicine and Policy; steering committee member for the London Joint Working Group on Hepatitis C and Substance Use and the European Hepatitis C Platform; and board member for the Global Congress for Qualitative Health Research. 

Some background about how she came to work in the harm reduction field can be found in this brief video:


Public Health, Environments and Society
Faculty of Public Health and Policy


Magdalena contributes lectures to the Qualitative Methods and Sociology of Health MSc Modules. Her PhD students are conducting qualitative research in the areas of harm reduction and HIV.


Magdalena is CI on collaborative NIHR grants and Fellowship holder for the NIHR Career Development Grant: "Promoting skin & soft tissue infection care and preventing AA amyloidosis among people who inject drugs in the UK: A mixed methods study."  

Her  research interests include: the social relations of harm reduction; community participation and mobilisation; stigma and discrimination; embodiment; autoethnography and qualitative methodologies.

Here she talks about her work on the Staying Safe project:

Research Area
Health inequalities
Mixed methods
Qualitative methods
Substance use
Social Sciences
Disease and Health Conditions
Kidney disease
Skin disease
United Kingdom
New Zealand

Selected Publications

High prevalence of albuminuria amongst people who inject drugs: A cross-sectional study.
McGowan CR; Wright T; Nitsch D; Lewer D; Brathwaite R; Scott J; Hope V; Ciccarone D; Dunn J; Gillmore J
Scientific Reports
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England.
Harrison GI; Murray K; Gore R; Lee P; Sreedharan A; Richardson P; Hughes AJ; Wiselka M; Gelson W; Unitt E
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).
Hickman M; Dillon JF; Elliott L; De Angelis D; Vickerman P; Foster G; Donnan P; Eriksen A; Flowers P; Goldberg D
BMJ open
Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis.
Lewer D; Freer J; King E; Larney S; Degenhardt L; Tweed EJ; Hope VD; Harris M; Millar T; Hayward A
A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK.
Guise A; Witzel TC; Mandal S; Sabin C; Rhodes T; Nardone A; Harris M
BMC infectious diseases
See more Publications